Antimicrobial innovation doesn’t fail in the lab.

It fails in execution.
We work at the intersection of microbiology, materials science, regulation, and markets to turn promising technologies into products customers trust—and buy.

The CleanOps Collective

An illustration of a black wireframe globe with longitude and latitude lines on a black background.

HI THERE. WE’RE THE CLEANOPS COLLECTIVE

Don’t have a PhD on staff or a go-to-market strategist? We do. We’ll lend you ours.

We bring top-tier professional expertise and a powerful network of partner professionals and organizations directly to your team.

If you’ve ever been told “this is great technology, but…”—you’re in the right place.

GET STARTED

We help technology teams translate complex science into credible products, clear claims, and viable commercial pathways.

Who We Work With

Innovators, manufacturers, investors, and operators bringing antimicrobial technologies to healthcare, animal health, food, facilities, and restoration markets.

Who This is For

CleanOps Collective works with teams who understand that successful antimicrobial technologies require more than strong data.

This is for you if:

You’ve developed an antimicrobial or infection-control technology that works—but adoption has stalled
You’re navigating regulatory, claims, or positioning uncertainty and want clarity before you scale
You need to identify where your technology truly fits in the market—not just where it could work in theory
You’re preparing for commercial launch, scale-up, partnership, or acquisition and want execution risks surfaced early
You value direct, senior-level guidance over generic frameworks or optimistic validation
You want your technology to survive real-world use, buyer scrutiny, and long-term credibility

Optimize Your GTMS

We help companies align data, claims, and go-to-market strategy so promising technologies survive regulatory review, customer scrutiny, and real-world use.